Clinical Trials · NCT07465965
A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Shanghai World Leader Pharmaceutical Co., Ltd.
- Enrollment
- 60
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- Maximum Plasma Concentration (Cmax)